Antibody Response and Variant Cross-Neutralization After SARS-CoV-2 Breakthrough Infection.

Bates, Timothy A; McBride, Savannah K; Winders, Bradie; Schoen, Devin; Trautmann, Lydie; Curlin, Marcel E; Tafesse, Fikadu G

Bates, Timothy A; McBride, Savannah K; Winders, Bradie; Schoen, Devin; Trautmann, Lydie; Curlin, Marcel E; Tafesse, Fikadu G.

Bates TA; Department of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland.
McBride SK; Department of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland.
Winders B; Division of Infectious Diseases, Oregon Health & Science University, Portland.
Schoen D; Division of Infectious Diseases, Oregon Health & Science University, Portland.
Trautmann L; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Portland.
Curlin ME; Division of Infectious Diseases, Oregon Health & Science University, Portland.
Tafesse FG; Department of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland.

JAMA ; 327(2): 179-181, 2022 01 11.

Article in English | MEDLINE | ID: covidwho-1653102

Subject(s)

Antibodies, Neutralizing/blood; Antibodies, Viral/blood; COVID-19 Vaccines/immunology; COVID-19/immunology; SARS-CoV-2/immunology; COVID-19/diagnosis; COVID-19 Serological Testing; Humans; Immunoglobulin Isotypes/blood; Neutralization Tests; Polymerase Chain Reaction

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antibodies, Neutralizing / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 / Antibodies, Viral Type of study: Diagnostic study / Randomized controlled trials Topics: Vaccines / Variants Limits: Humans Language: English Journal: JAMA Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google